- Home
- AMIX
as 07-26-2024 4:00pm EST
Stocks
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | THE WOODLANDS |
| Market Cap: | 17.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 14.0M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.51 - $7.60 | Next Earning Date: | 08-06-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest AUTONOMIX MEDICAL INC News
AMIX Breaking Stock News: Dive into AMIX Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology
GlobeNewswire
4 days ago
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
GlobeNewswire
8 days ago
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License Agreement
ACCESSWIRE
11 days ago
Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer
GlobeNewswire
11 days ago
Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc.
GlobeNewswire
15 days ago
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform
GlobeNewswire
23 days ago
Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment
GlobeNewswire
a month ago
Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial
Compare AMIX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AMIX AUTONOMIX MEDICAL INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.